CTIC: CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia

New alert via PocketInfo for CTIC:

CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia

Press Releases: http://investors.celltherapeutics.com/phoenix.zhtml?c=92775&p=irol-news&nyo=0
SEC Filings: http://investors.celltherapeutics.com/phoenix.zhtml?c=92775&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8